These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25066844)

  • 21. Peginterferon alpha-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients.
    Kuboki M; Iino S; Okuno T; Omata M; Kiyosawa K; Kumada H; Hayashi N; Sakai T
    J Gastroenterol Hepatol; 2007 May; 22(5):645-52. PubMed ID: 17444850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance.
    Serre SB; Krarup HB; Bukh J; Gottwein JM
    J Virol; 2013 Dec; 87(23):12776-93. PubMed ID: 24049176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daclatasvir Prevents Hepatitis C Virus Infectivity by Blocking Transfer of the Viral Genome to Assembly Sites.
    Boson B; Denolly S; Turlure F; Chamot C; Dreux M; Cosset FL
    Gastroenterology; 2017 Mar; 152(4):895-907.e14. PubMed ID: 27932311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B; Chen S; Guan Y; Chen L
    PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner.
    Lee M; Yang J; Jo E; Lee JY; Kim HY; Bartenschlager R; Shin EC; Bae YS; Windisch MP
    Sci Rep; 2017 Mar; 7():44676. PubMed ID: 28333153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
    Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N
    J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1.
    Cheng M; Si Y; Niu Y; Liu X; Li X; Zhao J; Jin Q; Yang W
    J Virol; 2013 Sep; 87(17):9707-18. PubMed ID: 23824794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic response of wild and mutant core codon 70 strains of HCV genotype 1b to pegylated interferon-α and ribavirin therapy.
    Hu Z; Liu Y; Qiu L; Fan Z; Nie W; Liang S; Jin R
    Virol J; 2015 Dec; 12():220. PubMed ID: 26684004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.
    Haberstroh A; Schnober EK; Zeisel MB; Carolla P; Barth H; Blum HE; Cosset FL; Koutsoudakis G; Bartenschlager R; Union A; Depla E; Owsianka A; Patel AH; Schuster C; Stoll-Keller F; Doffoël M; Dreux M; Baumert TF
    Gastroenterology; 2008 Nov; 135(5):1719-1728.e1. PubMed ID: 18718838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and gene analysis of interferon alpha-resistant cell clones of the hepatitis C virus subgenome.
    Noguchi T; Otsubaki T; Ando I; Ogura N; Ikeda S; Shimotohno K
    Virology; 2008 Jun; 375(2):424-32. PubMed ID: 18353417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes.
    Gal-Tanamy M; Bachmetov L; Ravid A; Koren R; Erman A; Tur-Kaspa R; Zemel R
    Hepatology; 2011 Nov; 54(5):1570-9. PubMed ID: 21793032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-Mediated Cytokine Induction Determines Sustained Virus Control in Chronic Hepatitis C Virus Infection.
    Wandrer F; Falk CS; John K; Skawran B; Manns MP; Schulze-Osthoff K; Bantel H
    J Infect Dis; 2016 Mar; 213(5):746-54. PubMed ID: 26503984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of interferon alpha-resistant hepatitis C virus using cell culture system.
    Tran HT; Lim YS; Hwang SB
    FEBS Lett; 2011 Jan; 585(2):409-13. PubMed ID: 21187091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infection.
    Watanabe T; Sakamoto N; Nakagawa M; Kakinuma S; Itsui Y; Nishimura-Sakurai Y; Ueyama M; Funaoka Y; Kitazume A; Nitta S; Kiyohashi K; Murakawa M; Azuma S; Tsuchiya K; Oooka S; Watanabe M
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2537-45. PubMed ID: 21444704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anchoring interferon alpha to apolipoprotein A-I reduces hematological toxicity while enhancing immunostimulatory properties.
    Fioravanti J; González I; Medina-Echeverz J; Larrea E; Ardaiz N; González-Aseguinolaza G; Prieto J; Berraondo P
    Hepatology; 2011 Jun; 53(6):1864-73. PubMed ID: 21425312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection.
    Erickson AK; Seiwert S; Gale M
    Antivir Ther; 2008; 13(7):851-62. PubMed ID: 19043919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C Virus Deletion Mutants Are Found in Individuals Chronically Infected with Genotype 1 Hepatitis C Virus in Association with Age, High Viral Load and Liver Inflammatory Activity.
    Cheroni C; Donnici L; Aghemo A; Balistreri F; Bianco A; Zanoni V; Pagani M; Soffredini R; D'Ambrosio R; Rumi MG; Colombo M; Abrignani S; Neddermann P; De Francesco R
    PLoS One; 2015; 10(9):e0138546. PubMed ID: 26405760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous immunoglobulin plus interferon-alpha in autoimmune hepatitis C.
    Malaguarnera M; Guccione N; Musumeci S; Brogna A; Motta M; Di Fazio I
    BioDrugs; 2004; 18(1):63-70. PubMed ID: 14733608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caffeic acid inhibits HCV replication via induction of IFNα antiviral response through p62-mediated Keap1/Nrf2 signaling pathway.
    Shen J; Wang G; Zuo J
    Antiviral Res; 2018 Jun; 154():166-173. PubMed ID: 29656059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral activity of glycyrrhizin against hepatitis C virus in vitro.
    Matsumoto Y; Matsuura T; Aoyagi H; Matsuda M; Hmwe SS; Date T; Watanabe N; Watashi K; Suzuki R; Ichinose S; Wake K; Suzuki T; Miyamura T; Wakita T; Aizaki H
    PLoS One; 2013; 8(7):e68992. PubMed ID: 23874843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.